Encephalopathy Associated With Autoimmune Thyroid Disease

Autoimmune thyroid diseases (ATDs) are immune-endocrine disorders affecting the thyroid gland and, eventually, also a number of other systemic targets, including the brain and the nervous system. Encephalopathy associated with autoimmune thyroid disease (EAATD) is a rare, heterogeneous condition ari...

Full description

Bibliographic Details
Main Authors: li A. Raouf, Gianluca Tamagno
Format: Article
Language:English
Published: European Medical Journal 2014-07-01
Series:European Medical Journal Neurology
Subjects:
Online Access:http://emjreviews.com/wp-content/uploads/Encephalopathy-Associated-With-Autoimmune-Thyroid-Disease.pdf
id doaj-8c96472c303243d3ae0f633ec540391b
record_format Article
spelling doaj-8c96472c303243d3ae0f633ec540391b2020-11-24T21:22:34ZengEuropean Medical JournalEuropean Medical Journal Neurology2054-45292014-07-01217277Encephalopathy Associated With Autoimmune Thyroid Diseaseli A. Raouf0Gianluca Tamagno1Department of General Internal Medicine, St. Columcille’s Hospital, Loughlinstown, Co. Dublin, IrelandDepartment of General Internal Medicine, St. Columcille’s Hospital, Loughlinstown, Co. Dublin, IrelandAutoimmune thyroid diseases (ATDs) are immune-endocrine disorders affecting the thyroid gland and, eventually, also a number of other systemic targets, including the brain and the nervous system. Encephalopathy associated with autoimmune thyroid disease (EAATD) is a rare, heterogeneous condition arising from the background of an ATD. It is characterised by neurological and/or psychiatric symptoms with acute or sub-acute onset, and virtually any neurological or psychiatric symptom can appear. However, EAATD often presents with confusion, altered consciousness, seizures, or myoclonus. The majority of cases are associated with Hashimoto’s thyroiditis, but a number of patients with Graves’ disease have also been described. EAATD is likely an immune-mediated disorder. Its exact prevalence has not been precisely elucidated, with an increasing number of cases reported in the last few years. Most EAATD patients respond in a dramatic manner to corticosteroids. However, the immunosuppressive treatment may require a long course (up to 12 months). The increasing number of EAATD cases reported in the literature demonstrates a growing interest of the scientific community about this condition, which still requires a better definition of its pathophysiology, the diagnostic criteria, and the most appropriate management, including the long-term follow-up of patients. The current clinical evidence about EAATD is mostly based on the report of single cases or small cohort studies. In this review, we present the current knowledge about EAATD, with a dedicated focus to the clinical management of the patients from a diagnostic and therapeutic perspective.http://emjreviews.com/wp-content/uploads/Encephalopathy-Associated-With-Autoimmune-Thyroid-Disease.pdfEncephalopathyGraves’ diseaseHashimoto’s thyroiditisthyroid
collection DOAJ
language English
format Article
sources DOAJ
author li A. Raouf
Gianluca Tamagno
spellingShingle li A. Raouf
Gianluca Tamagno
Encephalopathy Associated With Autoimmune Thyroid Disease
European Medical Journal Neurology
Encephalopathy
Graves’ disease
Hashimoto’s thyroiditis
thyroid
author_facet li A. Raouf
Gianluca Tamagno
author_sort li A. Raouf
title Encephalopathy Associated With Autoimmune Thyroid Disease
title_short Encephalopathy Associated With Autoimmune Thyroid Disease
title_full Encephalopathy Associated With Autoimmune Thyroid Disease
title_fullStr Encephalopathy Associated With Autoimmune Thyroid Disease
title_full_unstemmed Encephalopathy Associated With Autoimmune Thyroid Disease
title_sort encephalopathy associated with autoimmune thyroid disease
publisher European Medical Journal
series European Medical Journal Neurology
issn 2054-4529
publishDate 2014-07-01
description Autoimmune thyroid diseases (ATDs) are immune-endocrine disorders affecting the thyroid gland and, eventually, also a number of other systemic targets, including the brain and the nervous system. Encephalopathy associated with autoimmune thyroid disease (EAATD) is a rare, heterogeneous condition arising from the background of an ATD. It is characterised by neurological and/or psychiatric symptoms with acute or sub-acute onset, and virtually any neurological or psychiatric symptom can appear. However, EAATD often presents with confusion, altered consciousness, seizures, or myoclonus. The majority of cases are associated with Hashimoto’s thyroiditis, but a number of patients with Graves’ disease have also been described. EAATD is likely an immune-mediated disorder. Its exact prevalence has not been precisely elucidated, with an increasing number of cases reported in the last few years. Most EAATD patients respond in a dramatic manner to corticosteroids. However, the immunosuppressive treatment may require a long course (up to 12 months). The increasing number of EAATD cases reported in the literature demonstrates a growing interest of the scientific community about this condition, which still requires a better definition of its pathophysiology, the diagnostic criteria, and the most appropriate management, including the long-term follow-up of patients. The current clinical evidence about EAATD is mostly based on the report of single cases or small cohort studies. In this review, we present the current knowledge about EAATD, with a dedicated focus to the clinical management of the patients from a diagnostic and therapeutic perspective.
topic Encephalopathy
Graves’ disease
Hashimoto’s thyroiditis
thyroid
url http://emjreviews.com/wp-content/uploads/Encephalopathy-Associated-With-Autoimmune-Thyroid-Disease.pdf
work_keys_str_mv AT liaraouf encephalopathyassociatedwithautoimmunethyroiddisease
AT gianlucatamagno encephalopathyassociatedwithautoimmunethyroiddisease
_version_ 1725995325117693952